![]() | ![]() |
Formats:
|
||||||||||||||||||
Hyperdynamic Plasticity of Chromatin Proteins in Pluripotent Embryonic Stem Cells 1National Cancer Institute National Institutes of Health Bethesda, Maryland 20892 2University of Mississippi Medical Center, Jackson, Mississippi 39216 3 Institute of Child Health London WC1N 1EH United Kingdom *Correspondence: mistelit/at/mail.nih.gov Summary Differentiation of embryonic stem (ES) cells from a pluripotent to a committed state involves global changes in genome expression patterns. Gene activity is critically determined by chromatin structure and interactions of chromatin binding proteins. Here, we show that major architectural chromatin proteins are hyperdynamic and bind loosely to chromatin in ES cells. Upon differentiation, the hyperdynamic proteins become immobilized on chromatin. Hyperdynamic binding is a property of pluripotent cells, but not of undifferentiated cells that are already lineage committed. ES cells lacking the nucleosome assembly factor HirA exhibit elevated levels of unbound histones, and formation of embryoid bodies is accelerated. In contrast, ES cells, in which the dynamic exchange of H1 is restricted, display differentiation arrest. We suggest that hyperdynamic binding of structural chromatin proteins is a functionally important hallmark of pluripotent ES cells that contributes to the maintenance of plasticity in undifferentiated ES cells and to establishing higher-order chromatin structure. Introduction Embryonic stem (ES) cells possess an unlimited potential to self-renew and the capacity to differentiate into multiple lineages. During differentiation, ES cells lose their pluripotency and undergo dramatic morphological and molecular changes. One of the key events during this process is the selective silencing and activation of specific subsets of genes (Eiges and Benvenisty, 2002;Keller, 1995; Loebel et al., 2003; Weiss and Orkin, 1996). In addition, the genome of differentiating ES cells undergoes global chromatin reorganizations via chromatin remodeling events and epigenetic modulations (Hajkova et al., 2002; Jaenisch and Bird, 2003; Rasmussen, 2003; Surani, 2001). These changes are brought about by the interaction of a multitude of proteins with chromatin and changes in chromatin structure. Chromatin is generally composed of transcriptionally permissive, less condensed euchromatin and the highly condensed and often repressed heterochromatin (Patterton and Wolffe, 1996). The core subunit of chromatin, the nucleosome, consists of a histone octamer of four core histones, H2A, H2B, H3, and H4, wrapped inside 146 bp of double-stranded DNA. Adjacent nucleosomes are connected via linker DNA bound by the linker histone H1. Higher-order organization of this basic subunit defines the nature of the chromatin structure and its accessibility. In addition to the four core histones, several additional histone variants are present in mammalian cells (Sarma and Reinberg, 2005). Although some of their functions are yet to be determined, some appear to play active cellular roles, such as H2Ax in DNA damage responses (Rogakou et al., 1999) or H3.3, which accumulates in actively transcribed regions of the genome (Ahmad and Henikoff, 2002). The interaction of proteins with chromatin is highly dynamic in vivo. Fluorescent recovery after photobleaching (FRAP) approaches have demonstrated that most chromatin proteins are highly mobile within the mammalian cell nucleus and transiently interact with chromatin in vivo (Phair et al., 2004). An exception to this rule is the core histones that bind relatively stably to chromatin (Kimura and Cook, 2001; Phair et al., 2004). Other structural chromatin proteins, such as linker histones and the heterochromatin protein HP1, have residence times on chromatin on the order of a few seconds to minutes (Cheutin et al., 2003; Festenstein et al., 2003; Lever et al., 2000; Misteli et al., 2000). These observations suggest that establishment, maintenance, and functional modulation of chromatin domains involve the dynamic interaction of proteins with chromatin. While it seems likely that chromatin proteins play key roles in bringing about the changes in genome expression patterns associated with ES cell differentiation and possibly also have a role in maintenance of pluripotency, little is known about how proteins interact with chromatin in pluripotent ES cells and whether their interactions are modulated as cells begin their differentiation process. In order to compare the interaction of proteins with chromatin in pluripotent cells to their behavior in differentiated cells, we analyze chromatin structure and chromatin protein dynamics in pluripotent mouse ES cells during early neuronal differentiation. Results Morphological Changes in Chromatin Structure during ES Cell Differentiation To compare nuclear architecture in pluripotent ES cells to that in lineage-committed cells, we investigated architectural features of the cell nucleus of murine R1 ES cells during their differentiation from pluripotent cells into neural progenitor cells (NPCs) (Lee et al., 2000). We triggered the differentiation of R1 cells by depletion of the leukemia inhibitory factor (LIF) from the medium, leading to formation of embryoid bodies (EBs) after 4 days and eventually NPCs within 7 days (see Experimental Procedures for details). We limited our analysis to undifferentiated ES cells, an early time point of 24 hr after withdrawal of LIF, and a later time point of 7 days to avoid the heterogeneity associated with EBs. The three selected time points consisted of largely homogenous populations suitable for imaging. As expected, more than 90% of pluripotent ES cells expressed the stem cells marker Oct4. After 24 hr, Oct4 expression was still highly abundant, but it was limited to roughly 80% of the cells, and after 7 days Oct4 was no longer detectable (Figures S1A and S1D; see the Supplemental Data available with this article online). The neural progenitor marker nestin was detected in ~2.5% of undifferentiated ES cells, in ~20% of cells after 24 hr, and in over 80% of 7-day-old NPCs (Figures S1B and S1D). By day 7, almost all of the progenitors are already committed to the neural lineage, as evidenced by immunostaining with TUJ1 antibody against the neuronal marker β-tubulin III, which was undetectable in both undifferentiated ES cells and cells after 24 hr (Figures S1C and S1D). To compare the global organization of the genome in pluripotent ES cells to early stages of differentiation, heterochromatin was visualized by double immunostaining of heterochromatin protein 1 (HP1α) and Oct4 (Figure 1A
The observed differentiation-induced increase in H3-triMeK9 is consistent with previous reports (Keohane et al., 1996; Lee et al., 2004), in which progress in differentiation was accompanied by both an increase in H3-triMeK9 as well as a decrease in the acetylation of histones H3 and H4, a modification generally associated with euchromatin (Muller and Leutz, 2001). To study histone modifications during differentiation of R1 ES cells, we used both Western blotting and immunofluorescence microscopy with antibodies specific for H3-triMeK9, pan-acetylated histone H3, or pan-acetylated histone H4. By using Western blot analysis, an increase was observed in H3-triMeK9, but not in HP1 expression during differentiation (Figure 1H Dynamics of Architectural Chromatin Proteins in ES Cells Heterochromatin domains are maintained by dynamic structural proteins including heterochromatin protein HP1 and linker histones (Cheutin et al., 2003; Festenstein et al., 2003; Lever et al., 2000; Misteli et al., 2000; Schmiedeberg et al., 2004). To ask whether proteinchromatin interactions differ in pluripotent ES cells compared to differentiated cells, we analyzed the in vivo binding properties of architectural chromatin proteins in living ES cells by using fluorescence recovery after photobleaching (FRAP). Using an established FRAP protocol (Cheutin et al., 2003), we measured the chromatin binding dynamics of HP1α-GFP expressed at low levels in undifferentiated ES cells, ES cells 24 hr after LIF withdrawal, or in NPCs (Figure 2A
To ask whether increased binding dynamics were limited to HP1 or were a general property of structural chromatin proteins, we determined the exchange dynamics of the linker histone H1° and the core histones H2B, H3, and H3.3 by using well-characterized functional YFP or GFP fusion proteins (Ahmad and Henikoff, 2002; Phair et al., 2004). In somatic cells, the recovery of H1 has previously been shown to take place over several minutes (Lever et al., 2000; Misteli et al., 2000), while the recovery time of core histones has been shown to be on the order of hours (Kimura and Cook, 2001; Phair et al., 2004). The overall recovery kinetics of transiently expressed H1°-GFP (Figure 2C Since ES cells cycle rapidly between S phase and M phase with short G1 and G2 phases, we sought to rule out that the observed differences in binding dynamics were due to the changed cell cycle dynamics of ES cells compared to NPCs. To this end, we arrested R1 ES cells stably expressing H1°-GFP at G1/S with aphidicolin and performed FRAP analysis every 2 hr for a total of 16 hr after release from the G1/S block (Figure 3
Reduced Binding of Endogenous Chromatin Proteins in Undifferentiated ES Cells To independently verify and extend the FRAP experiments to endogenous proteins, we tested the association of structural proteins with chromatin by biochemical extraction. Upon salt extraction of isolated nuclei, fractions of both endogenous H1 and HP1 were released at lower salt concentrations in ES cells than in NPCs (Figure 4A
Available Pools of Architectural Chromatin Proteins Affect Differentiation These results suggest that several key architectural chromatin proteins exist in undifferentiated ES cells in a hyperdynamic, loosely bound, or soluble fraction. To test whether the hyperdynamic nature of these proteins is functionally important for efficient ES cell differentiation, we asked whether perturbing the dynamic balance of core histone influences the ability of cells to differentiate. We first tested whether an increase in the hyperdynamic fraction of core histones affects differentiation. To this end, we analyzed ES cells lacking the nucleosome assembly factor HirA (Roberts et al., 2002). HirA is associated with the histone variant H3.3, promoting DNA synthesis-independent nucleosome assembly (Ray-Gallet et al., 2002; Tagami et al., 2004), and it is essential for development since HirA—/— mice die in utero (Roberts et al., 2002). We hypothesized that the absence of HirA from ES cells would result in reduced efficiency of incorporation of core histones H3 and H3.3 and, as a consequence, in an increased nucleoplasmic fraction of these core histones. FRAP analysis and biochemical extraction of endogenous core histones confirmed this prediction. FRAP analysis showed a dramatic increase in the rapidly recovering unbound and loosely bound fractiond of both H3 and H3.3 in undifferentiated ES cells (Figures 5A
When we analyzed the ability of HirA—/— ES cells to differentiate, we found accelerated progression through the early stages of differentiation (Figure 5E We conversely analyzed differentiation in ES cells in which the binding dynamics of chromatin proteins is inhibited. To this end, we took advantage of an H1° mutant with increased binding capacity to chromatin. Since the C-terminal domain of H1 contributes significantly to its binding (Hendzel et al., 2004; Misteli et al., 2000), duplication of this domain is expected to confer stronger binding of H1° to chromatin. We generated ES cells stably expressing H1°cc-GFP or a control H1°-GFP under a Zn-inducible metallothionein (MT) promoter (Figure 6A
To assess the effect of the dynamics of H1 binding on differentiation, we monitored the fate of H1°cc-GFP-expressing cells during the course of differentiation. When stable cell clones were grown in the absence of ZnCl2, they displayed normal growth kinetics similar to that of the wt ES cells (Figure 6C Hyperdynamic Binding Is a Property of Pluripotent Stem Cells The hyperdynamic binding of chromatin-associated proteins could either be a general feature of undifferentiated cells or might be a specific property of pluripotent cells. In order to distinguish between these two possibilities, we tested the dynamic behavior of HP1 and H2B in additional multipotent cell types (P19, C3H/10T1/2) and compared it to that in undifferentiated, but already lineage-committed, cell lines (P12, C2C12). P19 mouse embryonal carcinoma (EC) cells are multipotent progenitors that can give rise to all three germ cell layers (McBurney, 1993). C3H/10T1/2 mouse mesenchymal stem cells are pluripotent mesodermal progenitors capable of differentiating into myogenic, chondrogenic, adipogenic, and osteogenic lineages (Pinney and Emerson, 1989). When heterochromatin FRAP kinetics of HP1-GFP were measured in either P19 (Figure 7A
Discussion Based on quantitative single cell in vivo imaging and biochemical analysis of endogenous proteins, we report here that several major architectural chromatin proteins exist in undifferentiated ES cells in a hyperdynamic fraction. This soluble or loosely bound fraction of chromatin proteins is a hallmark of pluripotent ES cells and is not a general feature of differentiation processes, as it does not occur in unilineage differentiating cells. We propose that this loosely bound or soluble pool of structural chromatin proteins contributes to the maintenance of the pluripotent state of ES cells and is essential in the early stages of ES cell differentiation for reshaping the global architecture of the genome, particularly for the reorganization of heterochromatin. Genome Architecture during ES Cell Differentiation By comparing the morphological appearance of heterochromatin regions in undifferentiated pluripotent ES cells and ES cell-derived neuronal precursor cells, we find evidence that heterochromatin undergoes substantial spatial rearrangements during the very earliest stages of ES cell differentiation. While heterochromatin showed a more dispersed pattern, heterochromatin in NPCs appeared more similar to what is typically observed in somatic cell types showing heterochromatin compaction and concentration in distinct foci. In addition, in ES cells, FISH signals of satellite repeats show a more diffuse signal not restricted to distinct foci, and these regions became more condensed in NPCs. These results resemble the differences in heterochromatin foci observed between undifferentiated F9 cells and after treatment with retinoic acid (Cammas et al., 2002). In another system, no significant differences in the extent of centromere clustering were observed between undifferentiated human ES cells and two diploid differentiated cell types, including a lymphoblastoid cell line (FATO LCL) and primary fibroblasts (Wiblin et al., 2005). However, centromeres in ES cells were mainly found within the nuclear interior, whereas, in differentiated cells, centromeres tend to localize at the nuclear periphery (Wiblin et al., 2005). If indeed pericentric heterochromatin is confined to a smaller portion of the nuclear interior in undifferentiated ES cells, this might explain the seemingly fewer, and larger, heterochromatin foci detected in these cells. These morphological changes are paralleled by an increase in H3-triMeK9, an epigenetic marker for silenced heterochromatin, and a decrease in acetylation of H3 and H4, which are both associated with transcriptionally active euchromatin. These morphological changes and the increase in epigenetic histone modifications characteristic of euchromatin suggest that chromatin in ES cells assumes a globally more open conformation than in differentiated or partially differentiated cells. These chromatin properties of ES cells might reflect a functionally important hallmark of pluripotency. Hyperdynamic Chromatin Proteins Are a Hallmark of Pluripotent ES Cells ES cells possess two qualities that distinguishes them from other cell types: they retain an unlimited capacity to self-renew, and, unlike immortalized cells, they are also able to generate the three embryonic germ layers and further differentiate to essentially every type of cell and tissue (O’Shea, 2004). This unlimited potential suggests that their genome has not yet been determined to fit any particular cell type and is still plastic. We suggest that hyperdynamic binding is a hallmark of pluripotency. This conclusion is supported by the presence of a hyperdynamic fraction in all pluripotent cell lines (R1, parental HirA cells, P19, and C3H/10T1/2) analyzed here. More importantly, we were unable to detect a hyperdynamic fraction in three undifferentiated, but lineage-committed, cell lines (NPC, PC12, and C2C12). The hyperdynamic nature of chromatin protein binding may contribute to maintaining chromatin in a globally relatively open, plastic state and, in this way, to the maintenance of pluripotency. Our data support a model in which ES cells preserve the potential to differentiate into multiple cell types by maintaining a loosely bound fraction of histones and other chromatin-associated proteins, which through free exchange with bound histones and chromatin, generate a state of active, “breathing” chromatin. Hyperdynamic Binding in Genome Reorganization The transition from undifferentiated, pluripotent ES cells to differentiated or partially differentiated cells involves dramatic changes in genome expression profiles (Ahn et al., 2004; Kelly and Rizzino, 2000; Loring et al., 2001; Sperger et al., 2003). During commitment, the parts of the genome that are not required for the newly forming lineage are presumably silenced (Eckfeldt et al., 2005). This silencing process involves epigenetic modifications and global reorganization of chromatin (Muller and Leutz, 2001), including condensation of heterochromatin into distinct foci as observed here. We suggest that the loosely bound fraction of architectural chromatin proteins is functionally important in the remodeling process during the early stages of differentiation by facilitating the structural chromatin changes that are required during this transition. As differentiation progresses and cell type-specific genome expression programs are implemented, the available structural proteins are incorporated into chromatin to establish the cell type-specific global chromatin architecture. When this occurs, the transcriptional potential of the genome is restricted. One noteworthy observation is the slight increase in the acetylation level of H4 24 hr after the onset of differentiation. The concurrent increase in both H4 acetylation and H3-triMeK9 methylation might suggest that, during the very early stages of differentiation, formation of heterochromatin parallels a transient rise in the transcriptional potential of euchromatin, allowing simultaneous activation and repression of different parts of the genome to fit the differentiation needs. Nevertheless, our observation that the reduction of dynamic binding of the major structural heterochromatin protein HP1 precedes the formation of distinct heterochromatin foci might suggest that immobilization of structural proteins is an early step in the differentiation-dependent chromatin remodeling and silencing process. Consistent with a globally highly transcriptionally active genome in ES cells, we find that the only structural chromatin protein without an increased hyperdynamic pool is H3.3, which preferentially associates with transcriptionally active regions (Ahmad and Henikoff, 2002). This finding is also consistent with the observed accelerated differentiation of HirA—/— cells, since, in those cells, less H3.3 is incorporated into the open chromatin regions, thus facilitating the formation of heterochromatin regions and promoting differentiation. Hyperdynamic Binding and Differentiation We provide two lines of evidence to suggest that the dynamic properties of architectural chromatin proteins are functionally relevant for the differentiation process. Upon inhibition of HirA, the available loosely bound pool of core histones H3 and H3.3 increases, as shown by FRAP analysis and biochemical extraction. This increased pool is now available for formation of heterochromatin, facilitating the rearrangements observed during early differentiation. On the other hand, the presence of a dominant, tightly binding linker histone reduces the availability of these molecules, thus impeding the formation of heterochromatin. Thus, prevention of chromatin proteins from assembly into chromatin accelerates differentiation, while restriction of linker histone in ES cells blocks differentiation. These data imply that the dynamic nature of chromatin is functionally important for stem cell differentiation. The observed fate of HirA—/— ES cells is in agreement with the phenotype of HirA—/— embryos. Upon loss of HirA, embryos typically die around day 10, although developmental defects occur much earlier, displaying severe early gastrulation defects at day 6 or earlier (Roberts et al., 2002). Similarly, HirA—/— ES cells exhibit efficient and rapid differentiation in the early stages, and 6 or 7 days after the onset of differentiation, they begin to deteriorate and die. While HirA—/— ES cells were able to differentiate into early NPCs they never progressed to the next level of differentiation to produce neurons (E.M., unpublished data). The fact that HirA—/— ES cells were able to undergo early differentiation also clearly demonstrates that these steps of differentiation are HirA independent, and that deposition of core histones must occur via different, possibly redundant, pathways. On the other hand, ES cells stably expressing the strongly bound H1°cc mutant displayed both reduced growth rate and perturbed differentiation. Thus, interference with the dynamic exchange of the linker histone H1 from chromatin affects two of the classical stem cell features. Although the mode of action of the H1°cc mutant is not clear, it seems likely that, upon expression of the mutant, the tight association between H1°cc and chromatin slowly out-competes the chromatin binding of the endogenous H1°. After a while, most of the linker histone will be replaced by H1°cc, thus restricting the dynamics of the genome globally and preventing its “breathing.” The rigid genome is likely less flexible, and the activation and suppression of the desired chromatin domains may be more difficult. Differentiation is hence blocked, and the cells die upon prolonged culturing. Taken together, our observations demonstrate the existence of a hyperdynamic fraction of architectural chromatin protein in the nucleus of pluripotent ES cells. We suggest that this soluble, more loosely bound fraction is a specific hallmark of ES cells. The presence of a hyperdynamic fraction of chromatin proteins points to altered chromatin structure in ES cells. We propose that these properties of chromatin have functional relevance by contributing to the maintenance of pluripotency of ES cells and facilitate the timely formation of higher-order chromatin domains during differentiation. Experimental Procedures Cells Mouse R1 ES cells were from A. Nagy (Toronto, Canada). R1 ES cells were grown on gelatin-coated plates with DMEM, 15% ES-grade fetal calf serum (FCS), 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 0.1 mM β-mercaptoethanol, and 1000 U/ml leukemia inhibitory factor (LIF). Nestin-positive NPCs were generated by using a protocol kindly provided by R. McKay (National Institutes of Health) (Lee et al., 2000). Briefly, ES cells were plated on bacterial culture dishes without LIF for 4 days to allow for embryoid body (EB) formation. EBs were replated on poly-L-lysin/fibronectin (Sigma)-coated plates in DMEM/F12 medium supplemented with ITS (5 μg/ml insulin, 50 mg/ml transferrin, 30 nM selenium chloride) and fibronectin (5 μg/ml). HirA—/— and HirA+/+ cells were grown on a feeder layer of γ-irradiated mouse embryonic fibroblasts (MEF). P19 embryonic carcinoma cells were grown in DMEM with 10% FBS and 1 mM sodium pyruvate. Differentiation was with 1 μM all-trans retinoic acid (ATRA). C3H/10T1/2 mesenchymal stem cells were grown in high-glucose DMEM with 10% FBS. Differentiation was with 2% horse serum. Rat PC12 pheochromocytoma cells were grown in DMEM with 8% horse serum and 8% FBS. Differentiation was induced with NGF (50 ng/ml). C2C12 myoblast cells were grown in DMEM with 10% FBS. Differentiation was with 2% horse serum. All cell culture media were supplemented with 2 mM glutamine, 100 U/ml penicillin, and 50 μg/ml streptomycin. Lipofectamine-2000 was used for all transfection experiments. All cell culture reagents were purchased from GIBCO-BRL (Invitrogen; Carlsbad, CA), and plates were purchased from Falcon (BD Biosciences, San Jose, CA), unless indicated otherwise. For photobleaching experiments, cells were grown in chambered cover glasses (Lab-Tek; Rochester, NY) or in glass-bottom culture dishes (MatTek; Ashland, MA). Plasmids CMV-H3-YFP and CMV-H3.3-YFP were kindly provided by K. Ahmad and S. Henikoff (Seattle, WA). CMV-HP1α-GFP, H1°-GFP under MT or CMV promoters, and CMV-H2B-GFP have previously been described (Cheutin et al., 2003; Misteli et al., 2000; Phair et al., 2004). The mutant MT-H1°cc-GFP consists of (from amino to carboxy termini) the entire coding region of H1° (amino acids 1-193), a single alanine residue, amino acids 94-193 of H1°, a single alanine residue, and the complete coding region of EGFP. The stable R1 clones were generated by introducing the expression vectors via electroporation, selection for resistance to G418, followed by identification of expressing clones by direct observation under epifluorescence. Antibodies and Immunofluorescence The following antibodies were used: Oct4 (goat polyclonal, Santa Cruz Biotechnologies, Santa Cruz, CA); Nestin (rabbit polyclonal), kindly provided by R. McKay (National Institutes of Health); H1, H2B, and H3 (rabbit polyclonal), kindly provided by M. Bustin (National Institutes of Health); TUJ1 (mouse monoclonal, Chemicon; Temecula, CA) against β-tubulin III; H3-triMeK9 (rabbit polyclonal, Abcam; Cambridge, MA); and HP1a (mouse monoclonal, Euromedex; Mundolsheim, France). Detection was with anti-rabbit or anti-mouse antibodies conjugated to either Texas red or FITC (Jackson Immuno-Research; West Grove, PA). IF was performed as described (Misteli et al., 2000). For EB imaging, EBs were paraffin embedded, sectioned to 7 μm intervals, and adhered to microscopic slides. Before IF, slides were treated with xylene (2 × 10 min), decreasing concentrations of EtOH (100%, 75%, 50%, and 25%), and PBT (2 3 5 min). DNA FISH Cells grown on glass coverslips were fixed (4% paraformaldehyde in PBS, 15 min), washed three times (PBS, 5 min each), permeabilized (0.5% Triton X-100 in PBS, 5 min), and washed again (PBS, 5 min, 2× SSC, 5 min). Probe was denatured at 90°C for 8 min and transferred to ice. Cells were denatured in 70% formamide/2× SSC solution for 7 min at 85°C. A 5′-biotinylated DNA probe (Invitrogen) recognizing the mouse major satellite repeat (GenBank accession number X06899) was applied overnight in a hybridization solution (50% formamide, 2× SSC, 10% dextran sulfate, 1 mg/ml tRNA) at 37°C. Washes (2× SSC, 5 min) were followed by blocking (3% BSA, 0.1% Tween-20, 4× SSC, 20 min) and detection with a streptavidin-Cy3 conjugate (Amersham Biosciences; Buckinghamshire, UK). A scrambled probe was used as a negative control. Probe sequences: major satellite: 5′-CTCGCCATATTTCACGTCCTAAAGT GTGTATTTCTC-3′; scrambled: 5′-TCTACGTTACCATCTCAGTGCG TATCGTTCTATTCA-3′ Salt Extractions For H1 and HP1, cells were washed in PBS, harvested, dounced in buffer A (0.32 M sucrose, 15 mM HEPES [pH 7.9], 60 mM KCl, 2 mM EDTA, 0.5 mM EGTA, 0.5% BSA, 0.5 mM spermidine, 0.15 mM spermine, and 0.5 mM DTT), layered over a cushion of high-sucrose Buffer A (30% sucrose), and centrifuged (15 min, 3000 × g). Pelleted nuclei were resuspended in buffer B (15 mM HEPES [pH 7.9], 60 mM KCl, 15 mM NaCl, 0.34 mM sucrose, 10% glycerol) and incubated with different NaCl or KCl concentrations (250-1000 mM) at 4°C for 30 min. Supernatants were separated on 4%-20% gradient Tris-HCl SDS gels (BioRad; Hercules, CA), blotted, and incubated with the appropriate antibodies. For core histones, the pellet remaining after salt treatment was extracted with 0.2 M H2SO4. Acid-soluble maerial was precipitated with 20% TCA and separated on 18% Tris-HCl SDS gels (BioRad). Micrococcal Nuclease Digestion Nuclei from undifferentiated ES cells or NPCs were prepared as described above and were digested with 1 U/ml micrococcal nuclease (MNase) (Worthington; Lakewood, NJ) in 10 mM Tris-HCl buffer supplemented with 5 mM CaCl2. Reactions were then centrifuged at 14,000 × g for 10 min, and supernatants were collected and run on 4%-20% gradient Tris-HCl SDS gels (BioRad). Microscopy and Photobleaching A Zeiss confocal LSM 510 META was used for all photobleaching experiments and fluorescent image acquisitions. The 30 mW Argon/Neon laser at 75% power was used for bleaching. Photobleaching and quantitation was performed as described (Cheutin et al., 2003; Lever et al., 2000; Phair et al., 2004). For core histones, half of the nucleus, including both euchromatin and heterochromatin, was bleached, and images were collected every 5 s for 10 min. For H1, 30 images were collected every 1 s. For HP1, the scan time between images was reduced to zero for maximal image collection speed. A total of 60 images were collected. Image analysis was performed with MetaMorph imaging software (Molecular Devices; Downingtown, PA). Supplemental Figures Click here to view.(870K, pdf) Supplemental Movie 1 FRAP of H3.3-YFP in wt ES cell. Shown are a total of 12 frames taken at 5 sec intervals. Bleaching was after frame 3. Note immediate recovery at frame 4. Click here to view.(1.5M, avi) Supplemental Movie 2 FRAP of H3.3-YFP in HirA-/- ES cell. Shown are a total of 12 frames taken at 5 sec intervals. Bleaching was after frame 3. Click here to view.(1.3M, avi) Acknowledgments We thank R. McKay and D. Hoeppner for reagents, technical assistance, and for critical comments on the manuscript; S. Henikoff, K. Ahmad, and M. Bustin for reagents; and T. Karpova for technical support. Imaging was performed at the National Cancer Institute Imaging Facility. This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. P.J.S. is supported by the British Heart Foundation. D.T.B. is supported by grant MCB0235800 from the National Science Foundation. T.M. is a Fellow of the Keith R. Porter Endowment for Cell Biology. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
FEBS Lett. 2002 Oct 2; 529(1):135-41.
[FEBS Lett. 2002]Curr Opin Cell Biol. 1995 Dec; 7(6):862-9.
[Curr Opin Cell Biol. 1995]Dev Biol. 2003 Dec 1; 264(1):1-14.
[Dev Biol. 2003]J Clin Invest. 1996 Feb 1; 97(3):591-5.
[J Clin Invest. 1996]Mech Dev. 2002 Sep; 117(1-2):15-23.
[Mech Dev. 2002]Dev Biol. 1996 Jan 10; 173(1):2-13.
[Dev Biol. 1996]Nat Rev Mol Cell Biol. 2005 Feb; 6(2):139-49.
[Nat Rev Mol Cell Biol. 2005]J Cell Biol. 1999 Sep 6; 146(5):905-16.
[J Cell Biol. 1999]Mol Cell. 2002 Jun; 9(6):1191-200.
[Mol Cell. 2002]Mol Cell Biol. 2004 Jul; 24(14):6393-402.
[Mol Cell Biol. 2004]J Cell Biol. 2001 Jun 25; 153(7):1341-53.
[J Cell Biol. 2001]Science. 2003 Jan 31; 299(5607):721-5.
[Science. 2003]Science. 2003 Jan 31; 299(5607):719-21.
[Science. 2003]Nature. 2000 Dec 14; 408(6814):873-6.
[Nature. 2000]Nat Biotechnol. 2000 Jun; 18(6):675-9.
[Nat Biotechnol. 2000]Dev Biol. 1996 Dec 15; 180(2):618-30.
[Dev Biol. 1996]Genesis. 2004 Jan; 38(1):32-8.
[Genesis. 2004]Curr Opin Genet Dev. 2001 Apr; 11(2):167-74.
[Curr Opin Genet Dev. 2001]Science. 2003 Jan 31; 299(5607):721-5.
[Science. 2003]Science. 2003 Jan 31; 299(5607):719-21.
[Science. 2003]Nature. 2000 Dec 14; 408(6814):873-6.
[Nature. 2000]Nature. 2000 Dec 14; 408(6814):877-81.
[Nature. 2000]Mol Biol Cell. 2004 Jun; 15(6):2819-33.
[Mol Biol Cell. 2004]Mol Cell. 2002 Jun; 9(6):1191-200.
[Mol Cell. 2002]Mol Cell Biol. 2004 Jul; 24(14):6393-402.
[Mol Cell Biol. 2004]Nature. 2000 Dec 14; 408(6814):873-6.
[Nature. 2000]Nature. 2000 Dec 14; 408(6814):877-81.
[Nature. 2000]J Cell Biol. 2001 Jun 25; 153(7):1341-53.
[J Cell Biol. 2001]Science. 2003 Jan 31; 299(5607):721-5.
[Science. 2003]J Cell Biol. 2001 Jun 25; 153(7):1341-53.
[J Cell Biol. 2001]Mol Cell Biol. 2004 Jul; 24(14):6393-402.
[Mol Cell Biol. 2004]Mol Cell Biol. 2002 Apr; 22(7):2318-28.
[Mol Cell Biol. 2002]Mol Cell. 2002 May; 9(5):1091-100.
[Mol Cell. 2002]Cell. 2004 Jan 9; 116(1):51-61.
[Cell. 2004]J Biol Chem. 2004 May 7; 279(19):20028-34.
[J Biol Chem. 2004]Nature. 2000 Dec 14; 408(6814):877-81.
[Nature. 2000]J Biol Chem. 2001 Feb 2; 276(5):3635-40.
[J Biol Chem. 2001]Int J Dev Biol. 1993 Mar; 37(1):135-40.
[Int J Dev Biol. 1993]Environ Health Perspect. 1989 Mar; 80():221-7.
[Environ Health Perspect. 1989]J Cell Sci. 2002 Sep 1; 115(Pt 17):3439-48.
[J Cell Sci. 2002]J Cell Sci. 2005 Sep 1; 118(Pt 17):3861-8.
[J Cell Sci. 2005]Biol Reprod. 2004 Dec; 71(6):1755-65.
[Biol Reprod. 2004]Dev Biol. 2004 Jan 15; 265(2):491-501.
[Dev Biol. 2004]Mol Reprod Dev. 2000 Jun; 56(2):113-23.
[Mol Reprod Dev. 2000]Restor Neurol Neurosci. 2001; 18(2-3):81-8.
[Restor Neurol Neurosci. 2001]Proc Natl Acad Sci U S A. 2003 Nov 11; 100(23):13350-5.
[Proc Natl Acad Sci U S A. 2003]Nat Rev Mol Cell Biol. 2005 Sep; 6(9):726-37.
[Nat Rev Mol Cell Biol. 2005]Mol Cell. 2002 Jun; 9(6):1191-200.
[Mol Cell. 2002]Mol Cell Biol. 2002 Apr; 22(7):2318-28.
[Mol Cell Biol. 2002]Nat Biotechnol. 2000 Jun; 18(6):675-9.
[Nat Biotechnol. 2000]Science. 2003 Jan 31; 299(5607):721-5.
[Science. 2003]Nature. 2000 Dec 14; 408(6814):877-81.
[Nature. 2000]Mol Cell Biol. 2004 Jul; 24(14):6393-402.
[Mol Cell Biol. 2004]Nature. 2000 Dec 14; 408(6814):877-81.
[Nature. 2000]Science. 2003 Jan 31; 299(5607):721-5.
[Science. 2003]Nature. 2000 Dec 14; 408(6814):873-6.
[Nature. 2000]Mol Cell Biol. 2004 Jul; 24(14):6393-402.
[Mol Cell Biol. 2004]